People · Operator

John U. Scheller

Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology

1
Companies
1
Filings
$4.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Semba Biosciences IncBiotechnologySeed$4.5M$133.2M2018
Operator network

John U. Scheller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Kenneth U Johnson · 5 companies · 1 sharedKenneth U JohnsonSteve Gordon · 2 companies · 1 sharedSteve GordonAndrew DeMarco · 1 companies · 1 sharedAndrew DeMarcoAndrew U DeMarco · 1 companies · 1 sharedAndrew U DeMarcoAnil U Oroskar · 1 companies · 1 sharedAnil U OroskarAsha U Oroskar · 1 companies · 1 sharedAsha U OroskarJoerg Baier · 1 companies · 1 sharedJoerg BaierJoerg U Baier · 1 companies · 1 sharedJoerg U BaierJohn F. Hardin · 1 companies · 1 sharedJohn F. HardinLisa A Johnson · 1 companies · 1 sharedLisa A JohnsonRobert C Mierendorf · 1 companies · 1 sharedRobert C Mierendo…Robert Mierendorf · 1 companies · 1 sharedRobert MierendorfStanley U Gembicki · 1 companies · 1 sharedStanley U GembickiStelios U Papadopoulos · 1 companies · 1 sharedStelios U Papadop…Semba Biosciences Inc · $4.5M raisedSemba Biosciences IncJohn U. SchellerJS
John U. Scheller Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside John U. Scheller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Kenneth U Johnson15
Steve Gordon12
Lisa A Johnson11
Stelios U Papadopoulos11
Andrew U DeMarco11
Robert C Mierendorf11
Stanley U Gembicki11
Asha U Oroskar11
Anil U Oroskar11
Joerg Baier11
Robert Mierendorf11
Andrew DeMarco11
John F. Hardin11
Joerg U Baier11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.